• Neuropathic pain market to reach $25.2 billon by 2027: GlobalData expresspharma
    May 31, 2021
    The neuropathic pain market is the most valuable segment within the pain indications and was valued at $10.8 billion in 2020 globally. It is forecast to reach $25.2 billion by 2027 at a compound annual growth rate (CAGR) of 12.9 per cent.
PharmaSources Customer Service